D.E. Shaw & Co
PROK icon

D.E. Shaw & Co’s ProKidney PROK Stock Holding History

D.E. Shaw & Co’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,301
Closed -$77.4K – 4772
2024
Q3 		$77.4K Buy
+40,301
New +$91.5K ﹤0.01% 4274
2023
Q4 		– Sell
-27,616
Closed -$126K – 4548
2023
Q3 		$126K Buy
+27,616
New +$264K ﹤0.01% 3831
2022
Q3 		– Sell
-623,545
Closed -$6.2M – 5455
2022
Q2 		$6.2M Hold
623,545
– – 0.01% 1874
2022
Q1 		$6.16M Buy
623,545
+186,539
+43% +$1.84M 0.01% 2081
2021
Q4 		$4.33M Buy
437,006
+117,971
+37% +$1.17M ﹤0.01% 2541
2021
Q3 		$3.13M Buy
319,035
+219,035
+219% +$2.16M ﹤0.01% 2587
2021
Q2 		$1.01M Buy
+100,000
New +$1.01M ﹤0.01% 3524

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co's PROK Position: Q4 2024 in Review

D.E. Shaw & Co sold out of ProKidney (PROK) in Q4 2024, closing a stake of 40,301 shares — an estimated $77.4K sold.

D.E. Shaw & Co first reported a position in PROK in Q2 2021 and held it in 7 quarters. The position peaked at $6.2M in Q2 2022. 74 funds tracked by Wall St. Rank hold PROK as of Q4 2024.

  • D.E. Shaw & Co reported no remaining ProKidney position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 40,301 ProKidney shares in Q4 2024, an estimated $77.4K.
  • D.E. Shaw & Co first reported a position in ProKidney in Q2 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's ProKidney position peaked at $6.2M in Q2 2022.
  • 74 funds tracked by Wall St. Rank held ProKidney as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.